Galecto Inc. Contracts & Agreements
33 Contracts & Agreements
- Business Finance (8 contracts)
- Business Operations (3)
- Human Resources (19)
- Real Estate (2)
- Uncategorized (1)
- Form of Support Agreement (Filed With SEC on October 7, 2024)
- Asset Purchase Agreement, dated October 7, 2024, by and between the Company and Bridge Medicines LLC (Filed With SEC on October 7, 2024)
- Retention Compensation Agreement between Galecto, Inc. and Garrett Winslow, dated October 19, 2023 (Filed With SEC on August 12, 2024)
- Employment Agreement between Galecto, Inc. and Garrett Winslow, dated April 12, 2021 (Filed With SEC on August 12, 2024)
- 2020 Equity Incentive Plan, and forms of award agreements thereunder (Filed With SEC on March 8, 2024)
- Description of Capital Stock (Filed With SEC on March 8, 2024)
- Bonus Agreement between the Galecto Biotech ApS and Hans Schambye, dated September 26, 2023 (Filed With SEC on November 6, 2023)
- Retention Compensation Agreement between the Company and Jonathan Freve, dated September 26, 2023 (Filed With SEC on November 6, 2023)
- Description of Capital Stock (Filed With SEC on February 17, 2022)
- Amended Non-Employee Director Compensation Policy (Filed With SEC on February 9, 2022)
- English language summary of Lease Agreement between Galecto Biotech ApS and COBIS A/S, dated April 15, 2021 (Filed With SEC on August 5, 2021)
- Galecto, Inc. Separation Benefits Plan (Filed With SEC on July 6, 2021)
- 2020 Equity Incentive Plan, and forms of award agreements thereunder (Filed With SEC on March 29, 2021)
- Non-Employee Director Compensation Policy (Filed With SEC on November 23, 2020)
- Non-Employee Director Compensation Policy (Filed With SEC on October 22, 2020)
- English language summary of Lease Agreement between Galecto Biotech ApS and COBIS A/S, dated May 4, 2020 (Filed With SEC on October 22, 2020)
- Employment Agreement between Galecto, Inc. and Jonathan Freve, dated March 11, 2020 (Filed With SEC on October 22, 2020)
- Form of Indemnification Agreement between the Registrant and each of its directors (Filed With SEC on October 22, 2020)
- Form of Indemnification Agreement between the Registrant and each of its executive officers (Filed With SEC on October 22, 2020)
- Senior Executive Cash Incentive Bonus Plan (Filed With SEC on October 22, 2020)
- 2020 Incentive Equity Plan, and form of award agreements thereunder (Filed With SEC on October 22, 2020)
- 2020 Stock Option and Grant Plan (Filed With SEC on October 22, 2020)
- Amended and Restated Investors Rights Agreement among the Registrant and certain of its stockholders, dated September 25, 2020 (Filed With SEC on October 22, 2020)
- Specimen Common Stock Certificate (Filed With SEC on October 22, 2020)
- Form of Underwriting Agreement (Filed With SEC on October 22, 2020)
- Amended and Restated Investors Rights Agreement among the Registrant and certain of its stockholders, dated September 25, 2020 (Filed With SEC on October 7, 2020)
- Amendment to Employment Agreement between Galecto, Inc. and Jonathan Freve, dated March 14, 2020 (Filed With SEC on October 7, 2020)
- Employment Agreement between Galecto, Inc. and Jonathan Freve, dated March 11, 2020 (Filed With SEC on October 7, 2020)
- Addendum to Employment Contract between Galecto Biotech ApS and Bertil E. Lindmark, dated January 15, 2020 (Filed With SEC on October 7, 2020)
- Employment Contract between Galecto Biotech ApS and Bertil E. Lindmark, dated November 28, 2019 (Filed With SEC on October 7, 2020)
- Addendum to Employment Contract between Galecto Biotech ApS and Anders H. Pedersen, dated August 24, 2017 (Filed With SEC on October 7, 2020)
- Employment Contract between Galecto Biotech ApS and Anders H. Pedersen, dated January 23, 2013, as amended on August 24, 2017 (Filed With SEC on October 7, 2020)
- Service Agreement between Galecto Biotech ApS and Hans Schambye, dated April 23, 2013 (Filed With SEC on October 7, 2020)
